Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|March 27, 2025
Therapeutic strategies for adrenocortical carcinoma: integrating genomic insights, molecular targeting, and immunotherapyJing Sun, Jiaxuan Huai, Wenhui Zhang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 18, 2014
Hypoxia induces dysregulation of lipid metabolism in HepG2 cells via activation of HIF-2αRisheng Cao, Xiaodan Zhao, Shuo Li, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 4, 2025
Review of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver DiseaseYifan Lu, Yixuan Xie, Xinyi Yang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 15, 2024
Institutional Nomogram for Estimating Risk of Metabolic Associated Fatty Liver Disease (MAFLD)Tiansu Lv, Jie Tian, Yaohuan Sun, et al.
Plos One|May 2, 2020
Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytesYanyan Wang, Xiqiao Zhou, Derrick Zhao, et al.
Communications Biology|January 10, 2026
Hepatic HMGCS2-derived β-hydroxybutyrate attenuates hippocampal insulin resistance and neuroinflammation to promote MASLD-induced cognitive functionLijuan Nie, Jing Sun, Weilong Xu, et al.
Biochemical Genetics|January 27, 2026
Potential Targets in Nonalcoholic Steatohepatitis Based on Bioinformatics Analysis and Machine Learning StrategiesTiansu Lv, Lingling Zhu, Yuan Han, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 5, 2026
Myricetin stabilizes PINK1 to activate mitophagy and ameliorate metabolic dysfunction-associated steatotic liver diseaseWeilong Xu, Lijuan Nie, Jing Cao, et al.
Frontiers in Endocrinology|May 19, 2025
Ameliorative effect and potential mechanism of hyperoside on diabetic retinopathyXu Yu, Hao Wu, Lei Zhou, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 28, 2026
Hyperoside stabilizes ACAT1 to promote fatty acid oxidation and attenuate kidney fibrosis via the L-carnitine-SIRT3 axisChuchu Shan, Tamas Szili-Torok, GuanYun Yue, et al.
Pageof 6